ChinaDaily:Shanghai establishes immunology institute

2021-05-22

The Shanghai Immune Therapy Institute was established on Thursday as part of the city's efforts to accelerate developing basic and translational research in the immunological field to promote the city's biomedical industry.

PRNewswire：Artificial Intelligence helps IVF patients avoid invasive embryo genetic testing

2021-05-22

SAN FRANCISCO, April 29, 2021 /PRNewswire/ -- Life Whisperer, the fertility arm of AI healthcare company Presagen, has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF. Currently, PGT-A genetic

Global Times:German investor Angermayer to launch biotech SPAC in the US.

2021-05-22

German investor Christian Angermayer is planning to list a blank-cheque company in New York, embracing a trend that has seen a swathe of entrepreneurs tapping into investor interest in new offerings, two people close to the matter said.

PRNewswire：Frost & Sullivan Recognizes Palo Alto Networks as a Leader in the US Healthcare Cybersecurity Market(

2021-05-22

Palo Alto Networks, the global cybersecurity leader, is transforming the healthcare industry by enabling the organizations to improve patient and employee experience, protect patient data and improve regulatory compliance throughout the continuum of care SANTA CLARA, Calif., May 5, 2021 /PRNews

PRNewswire:Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing

2021-05-22

Decheng Capital and Eclipse Ventures lead Series B round, bringing total funding to over $100 million SOUTH SAN FRANCISCO, Calif., May 5, 2021 /PRNewswire/ -- Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, today announced it has secured $82 mil

Novartis:Novartis Phase III Beovu® data show potential for fluid resolution in more diabetic macular edema patients

2021-05-22

In KESTREL and KITE, Beovu (brolucizumab) 6 mg met the primary endpoints of non-inferiority in change in best corrected visual acuity from baseline versus aflibercept 2 mg at year one in diabetic macular edema (DME) patients1

DANAHER:DANAHER ANNOUNCES RENOWNED SCIENTISTS TO JOIN NEW SCIENTIFIC ADVISORY BOARD

2021-05-22

DIVERSE SCIENTIFIC EXPERTISE AND PROPRIETARY INSIGHTS WILL SUPPORT COMPANY GROWTH AND IMPACT WASHINGTON, April 26, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), the global science and technology company, announced today the formation of a Scientific Advisory Board ("Board") to s

Bristol Myers Squibb:U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application fo

2021-05-22

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) for the adjuvant treatment of patients with surgically resected, high-risk mu

AstraZeneca:Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression wi

2021-05-22

AstraZeneca’s Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the US to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (ESKD), cardiovascular (CV) death and hospitalisation for heart failure

GSK:ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for pr

2021-05-22

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced the initiation of a rolling submission of a new drug application (NDA) with the US Food and Drug Administration (FDA) for investiga

Zheng Xiongwei presided over Cooperation Dialogue on Health Industry Chain at GHICC 2021 & CCPHI

2021-08-10

Yu Jia delivered a keynote speech at GHICC 2021 & CCPHI

2021-08-10

Wang Qian delivered a keynote speech at GHICC 2021 & CCPHI

2021-08-10

Helen Zhu delivered a keynote speech at GHICC 2021 & CCPHI

2021-08-10

Prof. Atta-ur-Rahman delivered a speech via video at GHICC 2021 & CCPHI

2021-08-10

Hon. Annette Nijs delivered a speech via video at GHICC 2021 & CCPHI

2021-08-10

Mr. Zheng Xiongwei Released the 2021 Global Healthcare Industry Cooperation Information at GHICC 2021 & CCPHI

2021-08-10

Shi Shengyi delivered a keynote speech at GHICC 2021 & CCPHI

2021-08-10

Mr. Qin Xiaoling delivered a keynote speech at GHICC 2021 & CCPHI

2021-08-10

Mr. Zhou Hui presided over the keynote speech at GHICC 2021& CCPHI

2021-08-10